The clinical trial biorepository & archiving systems market sales was estimated to be worth US$ 3.5 billion in 2021 and is projected to rise at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2032, per a recent Future Market Insights report. By the end of 2032, the market is projected to be …
Category Archives: Healthcare Trends
Veterinary Endoscopes Market Poised for a Skyrocketing Surge, Aiming for a Staggering US$560.3 Million Milestone by 2032-FMI Projection
According to Future Market Insights’ Industry Analysis Report on veterinary endoscopes market sales, endoscope sales are expected to reach US$ 227.2 million globally in 2021. Between 2022 and 2032, the market is predicted to rise by 8.7%, a rate significantly quicker than in the past. With an absolute financial potential of around US$ 216 million …
Global Skin Antiseptic Industry is anticipated to grow US$ 3.4 Billion by 2033, as per FMI analysis
The global skin antiseptic industry demand is anticipated to reach US$ 1.8 billion in 2022 and US$ 3.4 billion by the end of 2033, growing at a CAGR of 6.7% over that period. According to a new analysis by Future Market Insights, the alcohols sector by product will dominate the global market in 2022 with …
USA Medical Coding Industry is projected to become a profitable investment avenue, with a value of US$ 2.3 Billion by 2033 | FMI
As per the analysis by Future Market Insights, the USA medical coding industry demand is valued at US$ 1.0 Billion in 2023 and is projected to exhibit a CAGR growth of close to 8.4% over the forecast period, with an estimated valuation of US$ 2.3 Billion by 2033. Recent innovations in the field of medical …
Global 3D Printing Photopolymers Industry is anticipated to grow at a CAGR of 18.3%, reaching a value of US$ 5.0 Billion by 2033 | FMI
The global 3D printing photopolymers industry demand is anticipated to reach US$ 935.0 million in 2023. Between 2023 and 2033, the market is forecast to increase at a CAGR of 18.3%, and by the end of 2033, it is anticipated to reach US$ 5.0 billion. 3D printing, also known as additive manufacturing, has emerged as …
Global Nasopharyngeal Carcinoma Treatment Industry is expected to result in a US$ 2.1 Billion valuation by 2033, driven by Advanced Healthcare Solutions | FMI
During the forecast period 2023 to 2033, the global nasopharyngeal carcinoma treatment industry demand is expected to grow at a value of 5.9% CAGR, according to Future Market Insights. The industry is valued at US$ 1.18 Billion in 2023. By the year 2033, the global market for Nasopharyngeal carcinoma treatment is expected to rise up …
Global Non-Sterile Liquids/Suspensions Industry is poised for a 6.5% CAGR growth by 2033, driven chiefly by the advent of Personalized Medicine | FMI
The global non-sterile liquids/suspensions industry demand is anticipated to reach US$ 2.8 billion in 2023 and US$ 5.2 billion by the end of 2033. Between 2023 and 2033, the market is anticipated to develop at a 6.5% CAGR. According to a recent analysis by Future Market Insights, the oral dosage form would dominate the global …
Global Atrophic Vaginitis Treatment Industry is set to achieve an impressive US$ 6 Billion, maintaining an 8% CAGR between 2023 and 2033 | FMI
During the forecast period 2023 to 2033, the global atrophic vaginitis treatment industry demand is expected to grow at a value of 8% CAGR, according to Future Market Insights. The market is likely to reach US$ 2.78 Billion in 2023, By the year 2033, the global market for Atrophic vaginitis treatment is expected to rise …
Global Crohn’s Disease (CD) Treatment Industry is set to achieve a milestone, reaching US$ 17.80 Billion by 2033 | FMI Study
By the end of 2023, the global crohn’s disease (CD) treatment industry demand is expected to be worth US$ 11.68 billion. According to Future Market Insights, the market is expected to grow at a 4.3% CAGR from 2023 to 2033, with a market worth approximately US$ 17.80 billion by the end of 2033. The incidence …
Global AL Amyloidosis Therapeutics Industry is expected to witness substantial growth, aspiring for a value of US$ 4.56 Billion by 2033 | FMI
The global AL amyloidosis therapeutics industry demand is expected to be worth US$ 2.25 billion by the year of 2023. The market, which is estimated to be worth US$ 4.56 billion by 2033, will grow at a 7.3% CAGR, according to the market intelligence firm, Future Market Insights. AL amyloidosis is an uncommon illness characterized …